GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hayat Pharmaceutical Industries Co (AMM:HPIC) » Definitions » Scaled Net Operating Assets

Hayat Pharmaceutical Industries Co (AMM:HPIC) Scaled Net Operating Assets : 0.70 (As of Dec. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Hayat Pharmaceutical Industries Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Hayat Pharmaceutical Industries Co's operating assets for the quarter that ended in Dec. 2024 was JOD28.45 Mil. Hayat Pharmaceutical Industries Co's operating liabilities for the quarter that ended in Dec. 2024 was JOD2.83 Mil. Hayat Pharmaceutical Industries Co's Total Assets for the quarter that ended in Sep. 2024 was JOD36.62 Mil. Therefore, Hayat Pharmaceutical Industries Co's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2024 was 0.70.


Hayat Pharmaceutical Industries Co Scaled Net Operating Assets Historical Data

The historical data trend for Hayat Pharmaceutical Industries Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hayat Pharmaceutical Industries Co Scaled Net Operating Assets Chart

Hayat Pharmaceutical Industries Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.81 0.69 0.72 0.71 0.75

Hayat Pharmaceutical Industries Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.75 0.71 0.69 0.70

Competitive Comparison of Hayat Pharmaceutical Industries Co's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Hayat Pharmaceutical Industries Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hayat Pharmaceutical Industries Co's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hayat Pharmaceutical Industries Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Hayat Pharmaceutical Industries Co's Scaled Net Operating Assets falls into.


;
;

Hayat Pharmaceutical Industries Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Hayat Pharmaceutical Industries Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2024 )
=(Operating Assets (A: Dec. 2024 )-Operating Liabilities (A: Dec. 2024 ))/Total Assets (A: Dec. 2023 )
=(28.452-2.826)/34.398
=0.74

where

Operating Assets(A: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=37.497 - 9.045
=28.452

Operating Liabilities(A: Dec. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=6.652 - 3.291 - 0.535
=2.826

Hayat Pharmaceutical Industries Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2024 )
=(Operating Assets (Q: Dec. 2024 )-Operating Liabilities (Q: Dec. 2024 ))/Total Assets (Q: Sep. 2024 )
=(28.452-2.826)/36.617
=0.70

where

Operating Assets(Q: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=37.497 - 9.045
=28.452

Operating Liabilities(Q: Dec. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=6.652 - 3.291 - 0.535
=2.826

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hayat Pharmaceutical Industries Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Hayat Pharmaceutical Industries Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Hayat Pharmaceutical Industries Co Business Description

Traded in Other Exchanges
N/A
Address
Nile St. Al-Rajeeb, P.O. Box 1564, Amman, JOR, 11118
Hayat Pharmaceutical Industries Co is a Jordan based pharmaceutical manufacturing company. Its principal activity is producing human and veterinary in all its forms and medical stickers and stockings. The company is also involved in the production of medical supplies, body care lotions, cosmetics and initiating marketing campaigns as well as import and export operations. It has developed and registered hundred sixteen different dosage forms/pack sizes in the Jordan market representing fifty six different brands (molecules) in various therapeutic areas. Its products include Cardiovascular system, Infectious disease Dermatology, Gastrointestinal system, and Respiratory system.

Hayat Pharmaceutical Industries Co Headlines

No Headlines